デジタル治療市場 - 世界および地域別分析：分析と予測（2023年～2033年）

デジタル治療とは、様々な病状の予防、管理、治療のための医療処置、介入、サポートを提供するためにデジタル技術を使用する、エビデンスに基づく治療介入を指します。

これらのデジタル介入は、健康上の転帰を改善するように設計されており、単独の治療法として、または従来の医療療法と併用することができます。

デジタル治療市場は、しばしば「DTx」または「デジタル治療薬」と呼ばれ、ヘルスケア業界で急速に成長している分野です。デジタル治療薬は、モバイルアプリ、ソフトウェアプログラム、ウェアラブルデバイス、遠隔医療ソリューションなどのデジタル技術を使用して、様々な病状や健康課題に対する医療処置や介入を提供する、エビデンスに基づく治療介入です。

デジタル治療市場は、組織がヘルスケアを多様化し、価値提案を強化するための貴重な機会を提供します。エビデンスに基づくデジタル治療薬をポートフォリオに組み込むことで、ヘルスケアプロバイダー、製薬会社、保険会社は患者の転帰を改善し、患者エンゲージメントを高めることができます。

当レポートでは、世界のデジタル治療市場について調査し、市場の概要とともに、製品別、用途別、販売チャネル別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 世界のデジタル治療市場：概要

第2章 世界のデジタル治療市場：業界分析

• 主要な動向
• バリューチェーン分析
• 資金調達シナリオ
• 規制の枠組み
• 特許分析

第3章 世界のデジタル治療市場：市場力学

• 影響分析
• 市場促進要因
• 市場抑制要因
• 市場機会

第4章 世界のデジタル治療市場（製品別）

• 概要
• 成長シェアマトリックス
• ソフトウェア
• デバイス

第5章 世界のデジタル治療市場（用途別）

• 概要
• 成長シェアマトリックス
• 治療/患者ケア関連用途
  • 糖尿病
  • 神経障害
  • 禁煙
  • 慢性呼吸器疾患
  • 胃腸障害
  • 心血管疾患
  • 服薬アドヒアランス
  • リハビリと患者ケア
  • その他
• 予防用途

第6章 世界のデジタル治療市場（販売チャネル別）

• 概要
• 成長シェアマトリックス
• B2B
  • 保険会社
  • 企業の雇用主
  • 製薬会社
  • その他
• B2C
  • 患者
  • 介護者

第7章 世界のデジタル治療市場（地域別）

• 概要
• 北米
• 欧州
• ラテンアメリカ
• アジア太平洋
• 中東・アフリカ

第8章 世界のデジタル治療市場：競合考察と企業プロファイル

• 概要
• 主要な戦略と展開
• 市場シェア分析
• 世界のエコシステムの概要
• 企業プロファイル
  • Akili Interactive Labs, Inc.
  • Kaia Health
  • 2MORROW, Inc.
  • Click Therapeutics, Inc.
  • Biofourmis Inc
  • Glooko, Inc.
  • CureApp
  • Kaia Health Software GmbH
  • HiDoc Technologies GmbH (Cara Care)
  • Neurotrack
  • Lark Health
  • Omada Health, Inc.
  • ResMed
  • Vida Health
  • Vivante Health, Inc.

The digital therapeutic market report constitutes an extensive study of the digital therapeutics industry. Digital therapeutics (DTx) refers to evidence-based therapeutic interventions that use digital technologies to deliver medical treatments, interventions, and support for the prevention, management, or treatment of various medical conditions. These digital interventions are designed to improve health outcomes and can be used as standalone treatments or in conjunction with traditional medical therapies.

The key segments are:

• By Product
  • Software
  • Devices

• By Application
  • Treatment/ Patient Care-related Application
    • Diabetes
    • Neurological Disorder
    • Smoking Cessation
    • Chronic Respiratory Disorders
    • Gastrointestinal Disorder
    • Cardiovascular Diseases
    • Medication Adherence
    • Rehabilitation & Patient Care
    • Others
  • Preventive Applications
    • Nutrition Management
    • Lifestyle Management
    • Other

• By Sales Channel
  • Business-to-Business (B2B)
    • Insurance Providers
    • Corporate Employers
    • Pharmaceutical Companies
    • Others
  • Business-to-Consumers
    • Patients
    • Caregivers

The digital therapeutic market is segregated into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Data for each of these regions, along with country-level analysis is provided in the market study.

The key market players in the digital therapeutic market are: Akili Interactive Labs, Inc., HiDoc Technologies GmbH (Cara Care), Click Therapeutics, Inc., ResMed, and 2MORROW, Inc., Omada Health, Inc. among others.

Product Definition

According to BIS Research, the digital therapeutic market, often referred to as "DTx" or "digital therapeutics," is a rapidly growing sector within the healthcare industry. Digital therapeutics are evidence-based therapeutic interventions that use digital technologies, such as mobile apps, software programs, wearable devices, and telehealth solutions, to deliver medical treatments and interventions for various medical conditions and health challenges.

How can this report add value?

The digital therapeutic market presents a valuable opportunity for organizations to diversify their healthcare offerings and enhance their value proposition. By incorporating evidence-based digital therapeutics into their portfolios, healthcare providers, pharmaceutical companies, and insurers can improve patient outcomes and increase patient engagement.

The Digital Therapeutic Market Report is a concise analysis of the rapidly growing market including a snapshot of the current market landscape, covering key trends, opportunities, and challenges. The report also highlights different products, applications, and sales channels of the market such as software and devices. Additionally, the report profiles leading companies and startups in the market, offering insights into their strategies and innovations. With a focus on market size, growth projections, and regional dynamics, the digital therapeutic market report is a valuable resource for manufacturers, distributors, and other pharmaceutical companies.

Table of Contents

1. Global Digital Therapeutic Market: Overview

• 1.1. Product Definition
• 1.2. Inclusion and Exclusion Criteria
• 1.3. Key Findings

2. Global Digital Therapeutic Market: Industry Analysis

• 2.1. Key Trends
• 2.2. Value Chain Analysis
• 2.3. Funding Scenario
• 2.4. Regulatory Framework
• 2.5. Patent Analysis

3. Global Digital Therapeutic Market: Market Dynamics

• 3.1. Impact Analysis
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Market Opportunities

4. Global Digital Therapeutic Market (by Product)

• 4.1. Overview
• 4.2. Growth Share Matrix
• 4.3. Software
• 4.4. Devices

5. Global Digital Therapeutic Market (by Application)

• 5.1. Overview
• 5.2. Growth Share Matrix
• 5.3. Treatment/ Patient Care-related Application
  • 5.3.1. Diabetes
  • 5.3.2. Neurological Disorder
  • 5.3.3. Smoking Cessation
  • 5.3.4. Chronic Respiratory Disorders
  • 5.3.5. Gastrointestinal Disorder
  • 5.3.6. Cardiovascular Diseases
  • 5.3.7. Medication Adherence
  • 5.3.8. Rehabilitation & Patient Care
  • 5.3.9. Others
• 5.4. Preventive Applications
  • 5.4.1. Nutrition Management
  • 5.4.2. Lifestyle Management
  • 5.4.3. Other

6. Global Digital Therapeutic Market (by Sales Channel)

• 6.1. Overview
• 6.2. Growth Share Matrix
• 6.3. Business-to-Business (B2B)
  • 6.3.1. Insurance Providers
  • 6.3.2. Corporate Employers
  • 6.3.3. Pharmaceutical Companies
  • 6.3.4. Others
• 6.4. Business-to-Consumers
  • 6.4.1. Patients
  • 6.4.2. Caregivers

7. Global Digital Therapeutic Market (by Region)

• 7.1. Overview
• 7.2. North America
  • 7.2.1. Key Findings
  • 7.2.2. Market Size and Forecast
    • 7.2.2.1. North America Digital Therapeutics Market, by Product
    • 7.2.2.2. North America Digital Therapeutics Market, by Application
    • 7.2.2.3. North America Digital Therapeutics Market, by Sales Channel
    • 7.2.2.4. North America Digital Therapeutics Market, by Country
      • 7.2.2.4.1. U.S
      • 7.2.2.4.2. Canada
• 7.3. Europe
  • 7.3.1. Key Findings
  • 7.3.2. Market Size and Forecast
    • 7.3.2.1. Europe Digital Therapeutics Market, by Product
    • 7.3.2.2. Europe Digital Therapeutics Market, by Application
    • 7.3.2.3. Europe Digital Therapeutics Market, by Sales Channel
    • 7.3.2.4. Europe Digital Therapeutics Market, by Country
      • 7.3.2.4.1. U.K.
      • 7.3.2.4.2. Germany
      • 7.3.2.4.3. France
      • 7.3.2.4.4. Italy
      • 7.3.2.4.5. Spain
      • 7.3.2.4.6. Rest-of-Europe
• 7.4. Latin America
  • 7.4.1. Key Findings
  • 7.4.2. Market Size and Forecast
    • 7.4.2.1. Latin America Digital Therapeutics Market, by Product
    • 7.4.2.2. Latin America Digital Therapeutics Market, by Application
    • 7.4.2.3. Latin America Digital Therapeutics Market, by Sales Channel
    • 7.4.2.4. Latin America Digital Therapeutics Market, by Country
      • 7.4.2.4.1. Brazil
      • 7.4.2.4.2. Mexico
      • 7.4.2.4.3. Rest-of-Latin America
• 7.5. Asia-Pacific
  • 7.5.1. Key Findings
  • 7.5.2. Market Size and Forecast
    • 7.5.2.1. Asia-Pacific Digital Therapeutics Market, by Product
    • 7.5.2.2. Asia-Pacific Digital Therapeutics Market, by Application
    • 7.5.2.3. Asia-Pacific Digital Therapeutics Market, by Sales Channel
    • 7.5.2.4. Asia-Pacific Digital Therapeutics Market, by Country
      • 7.5.2.4.1. China
      • 7.5.2.4.2. Japan
      • 7.5.2.4.3. India
      • 7.5.2.4.4. Australia
      • 7.5.2.4.5. South Korea
      • 7.5.2.4.6. Rest-of-Asia-Pacific
• 7.6. Middle East and Africa
  • 7.6.1. Key Findings
  • 7.6.2. Market Size and Forecast
    • 7.6.2.1. Middle East and Africa Digital Therapeutics Market, by Product
    • 7.6.2.2. Middle East and Africa Digital Therapeutics Market, by Application
    • 7.6.2.3. Middle East and Africa Digital Therapeutics Market, by Sales Channel
    • 7.6.2.4. Middle East and Africa Digital Therapeutics Market, by Country
      • 7.6.2.4.1. K.S.A
      • 7.6.2.4.2. U.A.E.
      • 7.6.2.4.3. Israel
      • 7.6.2.4.4. South Africa
      • 7.6.2.4.5. Rest-of-Middle East and Africa

8. Global Digital Therapeutic Market: Competitive Insights and Company Profile

• 8.1. Overview
• 8.2. Key Strategies and Developments
  • 8.2.1. Synergistic Activities
  • 8.2.2. Regulatory Accreditations
  • 8.2.3. Product and Service Launches
  • 8.2.4. Acquisitions and Mergers
  • 8.2.5. Approvals
• 8.3. Market Share Analysis
• 8.4. Global Ecosystem Glimpse
• 8.5. Company Profiles
  • 8.5.1. Akili Interactive Labs, Inc.
    • 8.5.1.1. Company Overview
    • 8.5.1.2. Product Portfolio
    • 8.5.1.3. Recent Developments
    • 8.5.1.4. Analyst Perceptive
  • 8.5.2. Kaia Health
  • 8.5.3. 2MORROW, Inc.
  • 8.5.4. Click Therapeutics, Inc.
  • 8.5.5. Biofourmis Inc
  • 8.5.6. Glooko, Inc.
  • 8.5.7. CureApp
  • 8.5.8. Kaia Health Software GmbH
  • 8.5.9. HiDoc Technologies GmbH (Cara Care)
  • 8.5.10. Neurotrack
  • 8.5.11. Lark Health
  • 8.5.12. Omada Health, Inc.
  • 8.5.13. ResMed
  • 8.5.14. Vida Health
  • 8.5.15. Vivante Health, Inc.